Research indicates that experimental HIV vaccination regimens are probably not going to be very successful in preventing HIV acquisition.

Published Date: 13 Dec 2023

The HIV prevention study known as PrEPVacc, which involved 1,500 volunteer participants in East and Southern Africa and involved experimental vaccine regimens and a novel oral pre-exposure prophylaxis (PrEP), has halted.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Remote monitoring can improve recovery from cancer surgery

2.

Intractable cancers may respond better to treatment when using new radiation and high-performance computing.

3.

A Win for AI in Cancer; 2025's Transformative Drugs; FDA Clarifies 'Underway' Trials

4.

Conditional EU Nod for Weekly Pill in Pediatric Glioma

5.

high response rate when using a bispecific antibody to treat R/R multiple myeloma.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot